EntryPoint Capital’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-314	Closed	-$3.13K	–	1525
2024 Q1	$3.13K	Sell	314 -529	-63%	-$5.28K	﹤0.01%	1330
2023 Q4	$8.31K	Buy	+843	New	+$8.31K	0.01%	1174